Intellectual Property Rights in the Agenda of the Developing Countries. Intellectual Property Laws and Access to Medicines
Agreements on intellectual property rights, and especially bilateral agreements signed by the United States in recent years, have led to increased levels of intellectual property protection where each new agreement sets higher standards than the previous one. Until a little over 10 years ago, several countries did not grant patents for pharmaceuticals and foods.1 The Agreement on Trade Related Aspects of Intellectual Property (TRIPS) was the first global intellectual property agreement. It was concluded after almost 8 years of negotiations and marked a substantial change in the protection of intellectual property and access to medicines.